Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyoma × Simvastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Colorectal Neoplasms 3 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Pancreatic Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Smoldering Multiple Myeloma 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Retinoblastoma 1 Rectal Neoplasms 1 Perioperative Inflammatory Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1

Interventions

ulipristal acetate 12 Uterine Myomectomy 9 Uterine Artery Embolization 7 Bupivacaine 7 Tranexamic Acid 6 Leuprolide 6 Saline Solution 5 Mifepristone 5 Letrozole 4 Hysterectomy 4 epigallocatechin gallate 3 Surveys and Questionnaires 3 Sodium Chloride 3 Misoprostol 3 Lidocaine 3 Hysteroscopy 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 ulipristal 2 cetrorelix 2 Vitamin B 6 2 Tea 2 Tablets 2 Radiofrequency Ablation 2 Observation 2 Goserelin 2 Gonadotropins 2 Chorionic Gonadotropin 2 Anesthesia, Obstetrical 2 Anesthesia, General 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03400826 2025-07-14

Effects of Simvastatin on Uterine Leiomyoma Size

Johns Hopkins University

Phase 2 Recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡